GWLL
GOLDENWELL BIOTECH, INC.
Key Financials
Gross Profit
$12
0.0%
Operating Income
$-113326
↓ 395.0%
Revenue
$55
0.0%
Net Income
$-296471
↓ 48.4%
Total Liabilities
$379833.00
↑ 39.9%
EPS (Diluted)
$0.00
NaN%
Shareholders' Equity
$-343713.00
↓ 138.7%
Total Assets
$36120.00
↓ 83.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 7/1/2026 | View on SEC |
| 10-K | 7/1/2026 | View on SEC |
| 10-Q/A | 6/29/2026 | View on SEC |
| 10-Q/A | 6/26/2026 | View on SEC |
| 10-Q/A | 6/26/2026 | View on SEC |
| 8-K | 5/27/2026 | View on SEC |
| NT 10-Q | 5/12/2026 | View on SEC |
| NT 10-K | 3/31/2026 | View on SEC |
| 10-Q | 12/8/2025 | View on SEC |
| 10-Q | 9/12/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GWLL |
| Company Name | GOLDENWELL BIOTECH, INC. |
| CIK | 1800373 |
| Sector | Food and Kindred Products |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 2000 |
| SIC Description | Food and Kindred Products |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 440-666-7999 |